Bessemer Group’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-80,000
Closed -$666K 1419
2020
Q2
$666K Buy
+80,000
New +$666K ﹤0.01% 902